Tibolone versus 17β-estradiol/norethisterone: Effects on the proliferation of human breast cancer cells

European Journal of Gynaecological Oncology

Volumn 23, Issue 2, 2002, Pages 127-130

  Lippert, C ^a   Seeger, H ^a   Wallwiener, D ^a   Mueck, A O ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

17 estradiol; Breast cancer cell growth; Norethisterone; Tibolone

Indexed keywords

ESTRADIOL; GESTAGEN; NORETHISTERONE ACETATE; TIBOLONE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; NORETHISTERONE; PREGNANE DERIVATIVE; PROGESTERONE DERIVATIVE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER RISK; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GROWTH INHIBITION; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MENOPAUSE; MITOSIS INHIBITION; POSTMENOPAUSE OSTEOPOROSIS; BREAST TUMOR; CELL CULTURE; CELL DIVISION; CELL LINE; COMPARATIVE STUDY; FEMALE;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; ESTRADIOL; FEMALE; HUMANS; NORETHINDRONE; NORPREGNENES; PROGESTERONE CONGENERS; TUMOR CELLS, CULTURED;

EID: 0036010339     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Tibolone: A review
2. Effects of progestagens and Org OD14 in vitro and in vivo tumor models
3. Comparison of the effects of continuous combined and sequential combined medroxyprogesterone acetate-estradiol treatment on the proliferation of MCG-7 cells
4. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
5. Breast-cancer risk following long-term oestrogen-and oestrogen-progestin-replacement therapy
6. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
7. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
8. On the significance of in situ production of oestrogens in human breast cancer tissue
9. Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells
10. Effects of Org OD14 (Livial) and its metabolites on 17 betahydroxysteroid dehydrogenase activity in hormone-dependent MC-7 and T-47D breast cancer cells
11. The SEEM: Selective estrogen enzyme modulators in breast cancer
12. Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines
13. Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells
14. Mammographic and ultrasonographic study of changes in the breast related to HRT
15. Effects of tibolone on the breast
16. Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy
17. Estrogen replacement therapy in breast cancer survivors
18. Clinical experience with tibolone (Livial) over 8 years
19. Hormone replacement therapy as treatment of breast cancer - A phase II study of Org ODI4 (tibolone)